Results 21 to 30 of about 170,950 (291)

Is There a Risk of Misinterpretation of Potassium Concentration from Undetectable Hemolysis Using a POCT Blood Gas Analyzer in the Emergency Department?

open access: yesMedicina, 2022
Background and Objectives: Hemolysis is reported to be present in up to 10% of blood gas specimens in the central lab; however, few data on the incidence of hemolysis using a point-of-care testing (POCT) blood gas analysis are available in the setting of
Marianna Nigro   +17 more
doaj   +1 more source

Isohemagglutinins of Graft Origin after ABO-Unmatched Liver Transplantation [PDF]

open access: yes, 1984
THE increasing success of liver transplantation in recent years has provided an experimental model to study and document the hepatic synthesis of many plasma proteins.12345 The normal hepatobiliary tract has not been regarded as a major source of ...
Anderson   +13 more
core   +1 more source

Transcatheter paravalvular leak closure and hemolysis – a prospective registry

open access: yesArchives of Medical Science, 2016
Introduction : Paravalvular leak (PVL) related to a surgical prosthetic valve may be associated with clinically significant hemolysis. The influence of transcatheter PVL closure (TPVLC) on hemolysis remains uncertain.
Grzegorz Smolka   +7 more
doaj   +1 more source

Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up [PDF]

open access: yes, 2016
Primary autoimmune hemolytic anemia (P-AIHA) is a relatively uncommon and hetereogeneous disease characterized by the destruction of red blood cells due to anti-erythrocyte autoantibodies (AeAbs) in the absence of an associated disease [1–3].
ARMIENTO, DANIELE   +15 more
core   +1 more source

Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)-Comparison of VA- versus VV ECMO. [PDF]

open access: yesPLoS ONE, 2020
Venovenous (VV) and venoarterial (VA) extracorporeal membrane oxygenation (ECMO) are effective support modalities to treat critically ill patients. ECMO-associated hemolysis remains a serious complication.
Hannah Appelt   +7 more
doaj   +1 more source

Numerical hemolysis performance evaluation of a rotary blood pump under different speed modulation profiles

open access: yesFrontiers in Physiology, 2023
Introduction: Speed modulation methods have been studied and even used clinically to create extra pulsation in the blood circulatory system with the assistance of a continuous flow rotary blood pump.
Feng Huang   +6 more
doaj   +1 more source

Hemolysis research of implantable axial flow pump for two -step heart transplantation in children

open access: yesВестник трансплантологии и искусственных органов, 2017
Introduction. One of the main indicators characterizing mechanical circulatory support devices (artificial valve, implantable pumps, etc.) is trauma of blood cells.
O. Yu. Dmitrieva   +3 more
doaj   +1 more source

Isolated hemolytic anemia: an unusual manifestation of occult malignancy

open access: yesHematology Reports, 2014
Hemolysis is an uncommon and usually late complication of malignancy, and very rarely the presenting feature. Cancer-associated hemolysis may be immune-mediated, or may result from thrombotic microangiopathy accompanied by thrombocytopenia.
Matthew J. Butler, Ming Yin, Fahd Quddus
doaj   +1 more source

Bell Shape Curves of Hemolysis Induced by Silver Nanoparticles: Review and Experimental Assay

open access: yesNanomaterials, 2022
The hemolytic activity assay is a versatile tool for fast primary toxicity studies. This work presents a systematic study of the hemolytic properties of ArgovitTM silver nanoparticles (AgNPs) extensively studied for biomedical applications.
Roberto Luna-Vázquez-Gómez   +9 more
doaj   +1 more source

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study) [PDF]

open access: yes, 2013
This prospective, multicenter, single-arm, open-label Phase III study aimed to evaluate the efficacy and safety of Privigen (R) (10% liquid human intravenous immunoglobulin [IVIG], stabilized with l-proline) in patients with chronic inflammatory ...
Bauhofer, Artur   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy